#BiomX
$PHGE — Press Release

Tessera Defense and Homeland Security Inc. (formerly BiomX Inc., NYSE American: HLSQ) issued a press release on September 29, 2026, announcing its initial 2027 revenue target of $14–16 million and long-term targets of approximately $21 million in 2028 and $30...

🧵 continued ↓
September 29, 2026 at 8:16 PM
#PHGE BiomX Announces Positive FDA Feedback Supporting Next-Generation Phage Cocktail Program for Diabetic Foot Infections

https://www.stocktitan.net/news/PHGE/biom-x-announces-positive-fda-feedback-supporting-next-generation-1uqllk16fw5n.html
BiomX Announces Positive FDA Feedback Supporting Next-Generation Phage Cocktail Program for Diabetic Foot Infections
BiomX Inc. (NYSE American: PHGE) (“BiomX” or the
www.stocktitan.net
November 4, 2025 at 1:40 PM
🚀 BIOMX (#$PHGE) MOMENTUM: #$PHGE is absolutely flying, up 59.60% today! 🧬 With their Q1 2026 earnings report now out, the market is reacting to massive volume and renewed interest in Keeping a close eye on the flow from @GeminiTrading. 📈 #PHGE #BiomX #Biotech #StockMarket #Breakout #Investing
May 20, 2026 at 9:40 PM
Tessera Defense (formerly BiomX) listed on NYSE American this month, pivoting from biotech to unified physical and cyber security for critical infrastructure. The infrastructure layer nobody talks about until it fails.
Tessera Defense rebrands from BiomX to target critical infrastructure
Formerly BiomX, Tessera Defense listed on NYSE American under HLSQ on 11 September, pivoting to unified physical and cyber security platforms.
datatech.disruptsmedia.com
September 22, 2026 at 8:01 AM
'BiomX Inc., a clinical-stage company advancing natural and engineered phage therapies, announced its discontinuation of the ongoing Phase 2b clinical trial of nebulized phage therapy BX004 in patients with CF associated with chronic Pseudomonas aeruginosa infections'

ir.biomx.com/news-release...
BiomX Announces Discontinuation of Phase 2b BX004 Trial Following Internal Review | Mon, 12/08/2025 - 07:30
Following internal analysis and Data Monitoring Committee (DMC) feedback, the Company has elected to discontinue the BX004 Cystic Fibrosis (CF) Phase 2b trial  BiomX continues to see potential in BX01...
ir.biomx.com
January 16, 2026 at 4:43 PM
$PHGE -6.2% [The FDA paused BiomX's BX004 CF trial in the US due to the nebulizer device, not the drug product itself. BiomX has submitted data and expects a prompt resolution. EU trial continues as the nebulizer meets regulatory requirements.] ir.biomx.com/news-events/...
BiomX Provides Update on BX004 Phase 2b Trial for the Treatment of Patients with Cystic Fibrosis
ir.biomx.com
August 19, 2025 at 1:02 PM
Zorronet's new visual builder lets security teams compose autonomous AI workflows without code. Means faster iteration on threat response logic, less dependency on specialist engineers.
Zorronet launches no-code workflow builder for AI security platforms
BiomX subsidiary Zorronet has released a visual builder letting operators configure autonomous AI security workflows without writing code.
datatech.disruptsmedia.com
September 24, 2026 at 2:00 PM
Clinical-stage company, BiomX, said its therapy, BX211, was found to be safe and efficacious for this infection that was associated with Staphylococcus aureus. #IDsky
Investigational Phage Therapy Shows Positive Topline Results for Diabetic Foot Osteomyelitis
Clinical-stage company, BiomX, said its therapy, BX211, was found to be safe and efficacious for this infection that was associated with Staphylococcus aureus.
www.contagionlive.com
April 1, 2025 at 8:46 PM
BiomX acquires 10% of Motomea to accelerate electric motor validation for drones. Motor performance remains a critical constraint in UAV scaling, making this supply-chain play a strategic wedge into aerospace propulsion.
BiomX takes 10% stake in Motomea to bolster drone propulsion testing
The Israeli defence tech firm's minority buy-in targets electric motor validation, a chokepoint in the fast-scaling UAV supply chain.
disrupts.disruptsmedia.com
August 28, 2026 at 8:00 PM
Accès gratuit
Sponsor: Adaptive Phage Therapeutics, Mayo Foundation for Medical Education and Research, BiomX, Technophage Investigação E Desenvolvimento Em Biotecnologia S A, et par ESCMID Study Group for Non-traditional Antibacterial Therapy (ESGNTA).
December 14, 2024 at 10:16 AM
BiomX is onto something. It’s why I invested in PHGE. They are so close to being full players on the #NYSE , but one investor marked it to sell and detailed it again. I fully disagree. (I’m not a financial advisor, but I believe in supporting good biotech companies.)
February 12, 2025 at 8:40 PM
#Trading #Stocks
Stock Premarket - Jan 27, 2026

See StockQuakes.substack.com

UP
↑ NUWE Nuwellis, Inc. 117.9%
↑ HIND Vyome Holdings, Inc 55.0%
↑ PHGE Biomx Inc. 47.1%
↑ CYN Cyngn Inc. 30.0%
↑ NAMM Namib Minerals 26.7%
↑ GNTA Genenta Science S.P.A. 24.6%
↑ BZAI Blaize Holdings, Inc. 18.4%
StockQuakes | StockQuakes Team | Substack
Using AI to find stock market opportunities. Click to read StockQuakes, by StockQuakes Team, a Substack publication with hundreds of subscribers.
StockQuakes.substack.com
January 27, 2026 at 1:33 PM
Tessera Defense and Homeland Security CEO Issues Letter to Shareholders
Tessera Defense and Homeland Security (HLSQ)/b) has outlined its strategic shift, capital position and recent corporate actions in a CEO letter to shareholders dated September 15, 2026.The company’s common stock began trading on NYSE American under the symbol HLSQ on September 11, 2026, following a name change from BiomX (PHGE), with trading continuing without interruption. Tessera describes a unified security platform that connects cameras, sensors, detection technologies, artificial intelligence and other security systems to detect threats and coordinate real-time response, supported by subsidiaries Zorronet (AI-powered security intelligence) and DFSL (LADAR-based detection).For the quarter ended June 30, 2026, stockholders’ equity attributable to the company was $10.9 million and total equity was $17.6 million, including approximately $25.4 million of goodwill and intangible assets from April acquisitions. Over the last three months Tessera raised over $4 million through its at-the-market program at an average price of about $2.20 per share on a split-adjusted basis and effected a 1-for-10 reverse stock split on September 9, reducing authorized shares from 750 million to 150 million.
www.stocktitan.net
September 15, 2026 at 1:25 PM
Noted: Tessera Defense (formerly BiomX). BiomX Becomes Tessera Defense: When Sector Exit Demands Identity Reset.
The window is open. The house account is standing. → huanggoodman.com/brand-room
BiomX Becomes Tessera Defense: When Sector Exit Demands Identity Reset
Full analysis — Huang Goodman Intelligence
pops4-article-engine.billing-010.workers.dev
September 9, 2026 at 3:16 PM
Tessera Begins Trading Under HLSQ as Demand Grows for Connected Physical Security
Tessera Defense and Homeland Security (HLSQ), formerly BiomX (PHGE), has completed its rebrand as a physical security technology platform and its name and ticker changes are now effective as of September 11, 2026.The company’s common stock begins trading on the NYSE American under the symbol HLSQ on September 11, 2026, with trading continuing without interruption from the prior PHGE listing. Tessera targets digital infrastructure, energy assets, critical infrastructure and homeland security customers.The unified platform connects cameras, sensors, detection technologies, artificial intelligence and other systems, and is supported by subsidiaries Zorronet for AI-powered security intelligence and DFSL for LADAR-based detection. The name change date was selected in remembrance of the September 11 attacks.
www.stocktitan.net
September 11, 2026 at 12:30 PM
Tessera Defense (formerly BiomX). BiomX Becomes Tessera Defense: Identity Shift Demands Infrastructure.
90-day window just opened. The brands ready to quote this week win it. → huanggoodman.com/brand-room
BiomX Becomes Tessera Defense: Identity Shift Demands Infrastructure
Full analysis — Huang Goodman Intelligence
pops4-article-engine.billing-010.workers.dev
September 8, 2026 at 6:15 PM
BiomX (Tessera Defense). BiomX Becomes Tessera Defense: When Biotech Rewires as Defense.
Investor read: repositioning. Vendor read: new procurement cycle. POPS4 is watching. → huanggoodman.com/brand-room
BiomX Becomes Tessera Defense: When Biotech Rewires as Defense
Full analysis — Huang Goodman Intelligence
pops4-article-engine.billing-010.workers.dev
September 8, 2026 at 3:15 PM
BiomX (rebranding to Tessera Defense). BiomX Becomes Tessera Defense: A Sector Pivot Demands Identity Rebuild.
Investor read: repositioning. Vendor read: new procurement cycle. POPS4 is watching. → huanggoodman.com/brand-room
BiomX Becomes Tessera Defense: A Sector Pivot Demands Identity Rebuild
Full analysis — Huang Goodman Intelligence
pops4-article-engine.billing-010.workers.dev
September 5, 2026 at 9:15 AM
#PHGE BiomX: Zorronet Launches No-Code Control Over AI-Powered Autonomous Response Workflows

https://www.stocktitan.net/news/PHGE/biom-x-zorronet-launches-no-code-control-over-ai-powered-autonomous-dtil5gb1rbav.html
BiomX: Zorronet Launches No-Code Control Over AI-Powered Autonomous Response Workflows
BiomX (PHGE), to be renamed Tessera Defense and Homeland Security on September 11, 2026, announced that subsidiary Zorronet has launched a no-code capability for its AI-powered command-and-control platform.The new visual builder lets operational teams connect existing cameras, sensors, drones, gates and other on-site systems into autonomous response workflows without programming or developer support. Operators assemble site-, zone- or mission-specific logic from predefined capability blocks, modify it on screen, and run multiple workflows in parallel. The platform unifies diverse devices into one AI-managed layer that interprets activity, distinguishes behaviors, coordinates responses in real time, and can operate autonomously or with human-in-the-loop approvals. Zorronet’s software is already deployed across defense, homeland security, critical infrastructure and municipal environments in Israel.
www.stocktitan.net
September 4, 2026 at 1:28 PM
🚨 $PHGE
On September 1, 2026, BiomX Inc. announced that it will change its corporate name to Tessera Defense and Homeland Security Inc., effective at 12:01 a.m., Eastern Time, on September 11, 2026 . On August 31, 2026, the Company’s Board of Directors approved the Name Change and an amendment to...
SEC Filing: PHGE
Click to view the official SEC document.
www.sec.gov
September 1, 2026 at 9:00 PM
🚨 $PHGE
On August 28, 2026, BiomX Inc. announced that it will effect a one-for-ten (1-for-10) reverse stock split of its common stock, par value $0.0001 per share . The Reverse Stock Split was approved by the Company’s stockholders at a special meeting held on August 25, 2026, at which the stockh...
SEC Filing: PHGE
Click to view the official SEC document.
www.sec.gov
August 28, 2026 at 9:01 PM
🚨 $PHGE
BiomX Inc. held a Special Meeting of Stockholders on August 25, 2026 in a virtual meeting format.
SEC Filing: PHGE
Click to view the official SEC document.
www.sec.gov
August 25, 2026 at 9:14 PM
BiomX (NYSEAMERICAN:PHGE) Issues Earnings Results

BiomX (NYSEAMERICAN:PHGE – Get Free Report) announced its earnings results on Wednesday. The company reported ($0.37) earnings per share for the quarter, FiscalAI reports. BiomX Price Performance PHGE opened at $0.14 on Friday. The stock has a…
BiomX (NYSEAMERICAN:PHGE) Issues Earnings Results
BiomX (NYSEAMERICAN:PHGE – Get Free Report) announced its earnings results on Wednesday. The company reported ($0.37) earnings per share for the quarter, FiscalAI reports. BiomX Price Performance PHGE opened at $0.14 on Friday. The stock has a market capitalization of $1.65 million, a PE ratio of -0.04 and a beta of 1.35. BiomX has a [...]
news-area.com
August 22, 2026 at 12:28 AM